IL153547A0 - Process for preparing phenyl substituted azole derivatives - Google Patents
Process for preparing phenyl substituted azole derivativesInfo
- Publication number
- IL153547A0 IL153547A0 IL15354701A IL15354701A IL153547A0 IL 153547 A0 IL153547 A0 IL 153547A0 IL 15354701 A IL15354701 A IL 15354701A IL 15354701 A IL15354701 A IL 15354701A IL 153547 A0 IL153547 A0 IL 153547A0
- Authority
- IL
- Israel
- Prior art keywords
- phenyl substituted
- azole derivatives
- substituted azole
- preparing phenyl
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Executing Machine-Instructions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22093200P | 2000-07-26 | 2000-07-26 | |
| PCT/US2001/023541 WO2002008199A2 (en) | 2000-07-26 | 2001-07-26 | Efficient ligand-mediated ullmann coupling of anilines and azoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL153547A0 true IL153547A0 (en) | 2003-07-06 |
Family
ID=22825611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15354701A IL153547A0 (en) | 2000-07-26 | 2001-07-26 | Process for preparing phenyl substituted azole derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6541639B2 (ru) |
| EP (1) | EP1307431B1 (ru) |
| JP (1) | JP2004504384A (ru) |
| KR (1) | KR20030060872A (ru) |
| CN (1) | CN1444565A (ru) |
| AT (1) | ATE307804T1 (ru) |
| AU (1) | AU2001280813A1 (ru) |
| BR (1) | BR0112746A (ru) |
| CA (1) | CA2417426A1 (ru) |
| DE (1) | DE60114424T2 (ru) |
| EC (1) | ECSP034453A (ru) |
| ES (1) | ES2251501T3 (ru) |
| HU (1) | HUP0301699A3 (ru) |
| IL (1) | IL153547A0 (ru) |
| IS (1) | IS6695A (ru) |
| MX (1) | MXPA03000686A (ru) |
| NO (1) | NO20030393L (ru) |
| NZ (1) | NZ523271A (ru) |
| PL (1) | PL361233A1 (ru) |
| RU (1) | RU2003103706A (ru) |
| WO (1) | WO2002008199A2 (ru) |
| ZA (1) | ZA200300039B (ru) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2275395T3 (en) * | 2001-04-24 | 2017-02-20 | Massachusetts Inst Of Tech (Mit) | Copper-catalyzed provision of carbon-carbon compounds. |
| CN101597262A (zh) * | 2002-03-05 | 2009-12-09 | 特兰斯泰克制药公司 | 抑制配体与高级糖化终产物受体相互作用的单和双环吡咯衍生物 |
| JP2006501159A (ja) * | 2002-05-31 | 2006-01-12 | ロデイア・シミ | 炭素−炭素結合又は炭素−ヘテロ原子結合の形成方法 |
| CN1684944A (zh) | 2002-08-02 | 2005-10-19 | 麻省理工学院 | 铜催化形成碳－杂原子和碳－碳键的方法 |
| WO2004031143A2 (en) * | 2002-10-02 | 2004-04-15 | Bristol-Myers Squibb Company | Novel combination of a factor xa inhibitor and clopidogrel |
| MXPA05012350A (es) * | 2003-05-20 | 2006-05-25 | Transtech Pharma Inc | Antagonistas rage como agentes para la amiloidosis inversa y enfermedades asociadas con la misma. |
| EP1768947A1 (en) * | 2004-07-16 | 2007-04-04 | DSMIP Assets B.V. | Process for the preparation of an (hetero) arylamine |
| KR101999300B1 (ko) | 2007-03-12 | 2019-07-12 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치환된 헤테로환 융합 감마-카르볼린 합성 |
| EP2470510B1 (en) | 2009-09-30 | 2014-05-14 | TransTech Pharma, LLC | Substituted imidazole derivatives for treatment of alzheimers disease. |
| US9428506B2 (en) | 2012-04-14 | 2016-08-30 | Intra-Cellular Therapies, Inc. | Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders |
| EP2968320B1 (en) | 2013-03-15 | 2020-11-11 | Intra-Cellular Therapies, Inc. | Organic compounds |
| IL305990A (en) | 2013-12-03 | 2023-11-01 | Intra Cellular Therapies Inc | Compressed gamma-carboline heterocyclic compounds are modified for use in the treatment of type I and/or type II bipolar disorders |
| ES2961843T3 (es) | 2014-04-04 | 2024-03-14 | Intra Cellular Therapies Inc | Gamma-carbolinas condensadas con heterociclo deuteradas como antagonistas de los receptores de 5-HT2A |
| WO2015154030A1 (en) | 2014-04-04 | 2015-10-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2015171951A1 (en) * | 2014-05-07 | 2015-11-12 | The Regents Of The University Of Colorado, A Body Corporate | 2-(4-aryl-1h-imidazol-1-yl)aniline compounds |
| CN108883111B (zh) | 2016-01-26 | 2021-10-08 | 细胞内治疗公司 | 有机化合物 |
| AU2017238842B2 (en) | 2016-03-25 | 2019-06-20 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US10682354B2 (en) | 2016-03-28 | 2020-06-16 | Intra-Cellular Therapies, Inc. | Compositions and methods |
| JP2019513143A (ja) | 2016-03-28 | 2019-05-23 | イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． | 新規塩類および結晶 |
| EP3436016B1 (en) | 2016-03-28 | 2022-04-27 | Intra-Cellular Therapies, Inc. | Novel co-crystals |
| WO2018071233A1 (en) | 2016-10-12 | 2018-04-19 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
| US10961245B2 (en) | 2016-12-29 | 2021-03-30 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders |
| WO2018126143A1 (en) | 2016-12-29 | 2018-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
| IL268970B2 (en) | 2017-03-24 | 2023-12-01 | Intra Cellular Therapies Inc | Oral preparations of heterocyclic gamma carboline derivatives fused for absorption through mucous membranes |
| WO2019023063A1 (en) | 2017-07-26 | 2019-01-31 | Intra-Cellular Therapies, Inc. | ORGANIC COMPOUNDS |
| JP7223742B2 (ja) | 2017-07-26 | 2023-02-16 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| EP3762368B1 (en) | 2018-03-08 | 2022-01-26 | Incyte Corporation | Aminopyrazine diol compounds as pi3k-y inhibitors |
| WO2019237037A1 (en) | 2018-06-08 | 2019-12-12 | Intra-Cellular Therapies, Inc. | Novel methods |
| EP3609891A4 (en) | 2018-06-11 | 2021-04-14 | Intra-Cellular Therapies, Inc. | SYNTHESIS OF CONDENSED GAMMA CARBOLINE WITH SUBSTITUTED HETEROCYCLE |
| US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
| KR20210052472A (ko) | 2018-08-31 | 2021-05-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
| CN112584837A (zh) | 2018-08-31 | 2021-03-30 | 细胞内治疗公司 | 新方法 |
| WO2020113094A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6372658A (ja) | 1986-09-17 | 1988-04-02 | Sumitomo Chem Co Ltd | ニトロジフエニルアミン類の製造方法 |
| US5705697A (en) | 1997-01-30 | 1998-01-06 | Xerox Corporation | Arylamine processes |
| ZA985247B (en) | 1997-06-19 | 1999-12-17 | Du Pont Merck Pharma | Guanidine mimics as factor Xa inhibitors. |
-
2001
- 2001-07-25 US US09/912,950 patent/US6541639B2/en not_active Expired - Fee Related
- 2001-07-26 MX MXPA03000686A patent/MXPA03000686A/es unknown
- 2001-07-26 NZ NZ523271A patent/NZ523271A/en unknown
- 2001-07-26 CN CN01813378A patent/CN1444565A/zh active Pending
- 2001-07-26 WO PCT/US2001/023541 patent/WO2002008199A2/en active IP Right Grant
- 2001-07-26 PL PL36123301A patent/PL361233A1/xx not_active Application Discontinuation
- 2001-07-26 HU HU0301699A patent/HUP0301699A3/hu unknown
- 2001-07-26 CA CA002417426A patent/CA2417426A1/en not_active Abandoned
- 2001-07-26 RU RU2003103706/04A patent/RU2003103706A/ru not_active Application Discontinuation
- 2001-07-26 KR KR10-2003-7001155A patent/KR20030060872A/ko not_active Application Discontinuation
- 2001-07-26 AT AT01959231T patent/ATE307804T1/de not_active IP Right Cessation
- 2001-07-26 AU AU2001280813A patent/AU2001280813A1/en not_active Abandoned
- 2001-07-26 IL IL15354701A patent/IL153547A0/xx unknown
- 2001-07-26 ES ES01959231T patent/ES2251501T3/es not_active Expired - Lifetime
- 2001-07-26 DE DE60114424T patent/DE60114424T2/de not_active Expired - Fee Related
- 2001-07-26 BR BR0112746-2A patent/BR0112746A/pt not_active IP Right Cessation
- 2001-07-26 EP EP01959231A patent/EP1307431B1/en not_active Expired - Lifetime
- 2001-07-26 JP JP2002514105A patent/JP2004504384A/ja active Pending
-
2003
- 2003-01-02 ZA ZA200300039A patent/ZA200300039B/en unknown
- 2003-01-22 IS IS6695A patent/IS6695A/is unknown
- 2003-01-24 EC EC2003004453A patent/ECSP034453A/es unknown
- 2003-01-24 NO NO20030393A patent/NO20030393L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0301699A3 (en) | 2004-03-29 |
| ZA200300039B (en) | 2004-04-02 |
| MXPA03000686A (es) | 2003-06-06 |
| WO2002008199A3 (en) | 2002-06-13 |
| ATE307804T1 (de) | 2005-11-15 |
| RU2003103706A (ru) | 2004-08-10 |
| EP1307431B1 (en) | 2005-10-26 |
| EP1307431A2 (en) | 2003-05-07 |
| ECSP034453A (es) | 2003-03-31 |
| CA2417426A1 (en) | 2002-01-31 |
| WO2002008199A2 (en) | 2002-01-31 |
| US20020099225A1 (en) | 2002-07-25 |
| US6541639B2 (en) | 2003-04-01 |
| CN1444565A (zh) | 2003-09-24 |
| NZ523271A (en) | 2005-01-28 |
| IS6695A (is) | 2003-01-22 |
| ES2251501T3 (es) | 2006-05-01 |
| NO20030393L (no) | 2003-03-24 |
| DE60114424D1 (de) | 2005-12-01 |
| BR0112746A (pt) | 2003-09-09 |
| PL361233A1 (en) | 2004-10-04 |
| NO20030393D0 (no) | 2003-01-24 |
| DE60114424T2 (de) | 2006-07-27 |
| AU2001280813A1 (en) | 2002-02-05 |
| HUP0301699A2 (hu) | 2003-12-29 |
| JP2004504384A (ja) | 2004-02-12 |
| KR20030060872A (ko) | 2003-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL153547A0 (en) | Process for preparing phenyl substituted azole derivatives | |
| NZ506329A (en) | Inhibitors of phospholipase enzymes | |
| PL372799A1 (en) | New compounds | |
| GB0130341D0 (en) | Compounds | |
| PT1131318E (pt) | Processo para a producao de pirazoles 5-substituidos utilizando ditietanos | |
| HK1076807A1 (en) | Aryloxyphenyl and arylsulfanylphenyl derivatives | |
| PL369530A1 (en) | Chemical compounds | |
| YU5503A (sh) | Nesteroidni supresori zapaljenja | |
| IL163781A0 (en) | Purine derivatives as kinase inhibitors | |
| BG105009A (en) | Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline | |
| MX9700068A (es) | Compuestos y metodo para inhibir a la fosfodiesterasa iv. | |
| HK1031399A1 (en) | Process for synthesizing cox-2 inhibitors. | |
| RS20060250A (en) | 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, method for the production thereof, and their use as antiphlogistics | |
| MY137541A (en) | Polymerization catalyst activators, method of preparing, and their use in polymerization processes | |
| MY122453A (en) | Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines | |
| GB0011358D0 (en) | Novel use | |
| SE0103710D0 (sv) | Compounds | |
| AP2002002466A0 (en) | 3-heterocycliylpropanohydroxamic acid PCP INHIBITORS. | |
| MXPA03008205A (es) | Procedimiento para la preparacion de compuestos de imidazol. | |
| AU2002339192A1 (en) | 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors | |
| TW200510323A (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
| IT1293777B1 (it) | Processo per la preparazione di tetraazamacrocicli | |
| YU83100A (sh) | Fkbp inhibitori | |
| GB0103045D0 (en) | Organic Compounds | |
| CO5540298A2 (es) | Proceso para preparar un ligando de ppar de tiazol y polimorfos del mismo |